CF
57
-3
CHK
48
15
MCO
80
2
ACN
56
13
GOOG
67
2
QCOM
55
-4
NI
65
2
EBAY
47
-2
LEN
55
-9
LEG
27
-2
CME
42
-4
PNW
66
3
WAT
54
2
MS
64
7
SJM
38
-3
STZ
63
10
PYPL
43
-4
CVS
45
-4
NAVI
55
-2
FLR
52
4
CF
57
-3
CHK
48
15
MCO
80
2
ACN
56
13
GOOG
67
2
QCOM
55
-4
NI
65
2
EBAY
47
-2
LEN
55
-9
LEG
27
-2
CME
42
-4
PNW
66
3
WAT
54
2
MS
64
7
SJM
38
-3
STZ
63
10
PYPL
43
-4
CVS
45
-4
NAVI
55
-2
FLR
52
4
Financhill
Back

Erdene Resource Development Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
50

ERD.TO
Erdene Resource Development

Last Price:
0.52
Seasonality Move:
-0.68%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
50
Erdene Resource Development (ERD.TO) is a Sell

Is Erdene Resource Development a Buy, Sell or Hold?

  • The current Erdene Resource Development [ERD.TO] share price is $0.52. The Score for ERD.TO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ERD.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ERD.TO Stock Price Chart

What is Erdene Resource Development's stock price today?

  • The Erdene Resource Development share price today is $0.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ERD.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

ERD.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 73.84 Buy
Chaikin Money Flow: 597406 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.42 - 0.48) Buy
Bollinger Bands (100): (0.4 - 0.46) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

ERD.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.47 Buy
20-day SMA: 0.45 Buy
50-day SMA: 0.44 Buy
200-day SMA: 0.39 Buy
8-day EMA: 0.48 Buy
20-day EMA: 0.46 Buy
50-day EMA: 0.44 Buy
200-day EMA: 0.41 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Erdene Resource Development Earnings Growth & ERD.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Erdene Resource Development Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):